These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 22086924

  • 21. The redox regulator sulfiredoxin forms a complex with thioredoxin domain-containing 5 protein in response to ER stress in lung cancer cells.
    Chawsheen HA, Jiang H, Ying Q, Ding N, Thapa P, Wei Q.
    J Biol Chem; 2019 May 31; 294(22):8991-9006. PubMed ID: 31000628
    [Abstract] [Full Text] [Related]

  • 22. Sestrin 2 is not a reductase for cysteine sulfinic acid of peroxiredoxins.
    Woo HA, Bae SH, Park S, Rhee SG.
    Antioxid Redox Signal; 2009 Apr 31; 11(4):739-45. PubMed ID: 19113821
    [Abstract] [Full Text] [Related]

  • 23. Nuclear factor E2-related factor 2 dependent overexpression of sulfiredoxin and peroxiredoxin III in human lung cancer.
    Kim YS, Lee HL, Lee KB, Park JH, Chung WY, Lee KS, Sheen SS, Park KJ, Hwang SC.
    Korean J Intern Med; 2011 Sep 31; 26(3):304-13. PubMed ID: 22016591
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The sulfiredoxin-peroxiredoxin (Srx-Prx) axis in cell signal transduction and cancer development.
    Mishra M, Jiang H, Wu L, Chawsheen HA, Wei Q.
    Cancer Lett; 2015 Oct 01; 366(2):150-9. PubMed ID: 26170166
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Reduction of cysteine sulfinic acid in peroxiredoxin by sulfiredoxin proceeds directly through a sulfinic phosphoryl ester intermediate.
    Jönsson TJ, Murray MS, Johnson LC, Lowther WT.
    J Biol Chem; 2008 Aug 29; 283(35):23846-51. PubMed ID: 18579529
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Sulfiredoxin-1 protects against simulated ischaemia/reperfusion injury in cardiomyocyte by inhibiting PI3K/AKT-regulated mitochondrial apoptotic pathways.
    Zhang J, He Z, Guo J, Li Z, Wang X, Yang C, Cui X.
    Biosci Rep; 2016 Aug 29; 36(2):. PubMed ID: 26992405
    [Abstract] [Full Text] [Related]

  • 32. Peroxiredoxin III and sulfiredoxin together protect mice from pyrazole-induced oxidative liver injury.
    Bae SH, Sung SH, Lee HE, Kang HT, Lee SK, Oh SY, Woo HA, Kil IS, Rhee SG.
    Antioxid Redox Signal; 2012 Nov 15; 17(10):1351-61. PubMed ID: 22490042
    [Abstract] [Full Text] [Related]

  • 33. Sulfiredoxin-Peroxiredoxin IV axis promotes human lung cancer progression through modulation of specific phosphokinase signaling.
    Wei Q, Jiang H, Xiao Z, Baker A, Young MR, Veenstra TD, Colburn NH.
    Proc Natl Acad Sci U S A; 2011 Apr 26; 108(17):7004-9. PubMed ID: 21487000
    [Abstract] [Full Text] [Related]

  • 34. Redox regulation of lipopolysaccharide-mediated sulfiredoxin induction, which depends on both AP-1 and Nrf2.
    Kim H, Jung Y, Shin BS, Kim H, Song H, Bae SH, Rhee SG, Jeong W.
    J Biol Chem; 2010 Nov 05; 285(45):34419-28. PubMed ID: 20826812
    [Abstract] [Full Text] [Related]

  • 35. Mapping the phenotypic repertoire of the cytoplasmic 2-Cys peroxiredoxin - Thioredoxin system. 1. Understanding commonalities and differences among cell types.
    Selvaggio G, Coelho PMBM, Salvador A.
    Redox Biol; 2018 May 05; 15():297-315. PubMed ID: 29304480
    [Abstract] [Full Text] [Related]

  • 36. Characterization of plant sulfiredoxin and role of sulphinic form of 2-Cys peroxiredoxin.
    Iglesias-Baena I, Barranco-Medina S, Lázaro-Payo A, López-Jaramillo FJ, Sevilla F, Lázaro JJ.
    J Exp Bot; 2010 Mar 05; 61(5):1509-21. PubMed ID: 20176891
    [Abstract] [Full Text] [Related]

  • 37. Identification of intact protein thiosulfinate intermediate in the reduction of cysteine sulfinic acid in peroxiredoxin by human sulfiredoxin.
    Jönsson TJ, Tsang AW, Lowther WT, Furdui CM.
    J Biol Chem; 2008 Aug 22; 283(34):22890-4. PubMed ID: 18593714
    [Abstract] [Full Text] [Related]

  • 38. Molecular mechanism of the reduction of cysteine sulfinic acid of peroxiredoxin to cysteine by mammalian sulfiredoxin.
    Jeong W, Park SJ, Chang TS, Lee DY, Rhee SG.
    J Biol Chem; 2006 May 19; 281(20):14400-7. PubMed ID: 16565085
    [Abstract] [Full Text] [Related]

  • 39. Periovulatory expression of hydrogen peroxide-induced sulfiredoxin and peroxiredoxin 2 in the rat ovary: gonadotropin regulation and potential modification.
    Park JI, Jeon HJ, Jung NK, Jang YJ, Kim JS, Seo YW, Jeong M, Chae HZ, Chun SY.
    Endocrinology; 2012 Nov 19; 153(11):5512-21. PubMed ID: 22989627
    [Abstract] [Full Text] [Related]

  • 40. Nitric oxide activates an Nrf2/sulfiredoxin antioxidant pathway in macrophages.
    Abbas K, Breton J, Planson AG, Bouton C, Bignon J, Seguin C, Riquier S, Toledano MB, Drapier JC.
    Free Radic Biol Med; 2011 Jul 01; 51(1):107-14. PubMed ID: 21466852
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.